Target intelligence / Profile preview

Bile acid transporters

Molecular classification
Transporter, ATP-binding cassette transporter, Solute carrier family transporter
01

Overview

The regulation of blood cholesterol level via bile acid binding and excretion is not a single molecular target but rather a physiological process involving multiple **bile acid transporters**. These include canalicular membrane proteins such as the **bile salt export pump** (BSEP/ABCB11), **multidrug resistance-associated protein 2** (MRP2/ABCC2), **ATP-binding cassette subfamily G members 5 and 8** (ABCG5/G8), as well as uptake systems like the **sodium/taurocholate cotransporting polypeptide** (**NTCP/SLC10A1**) in hepatocytes. These transporters mediate the movement of bile acids from hepatocytes into the biliary tract, facilitating their eventual excretion in feces—a major route for eliminating excess cholesterol from the body since most hepatic cholesterol is converted into bile acids before being secreted. Pharmacologically, drugs such as **bile acid sequestrants** act by binding intestinal bile acids, preventing their reabsorption, which forces increased hepatic conversion of plasma cholesterol into new bile acids—thereby lowering circulating LDL-cholesterol. The process is tightly regulated at both transcriptional and post-translational levels by nuclear receptors including FXR, LXR, PPARs, which sense intracellular sterol/bile acid concentrations and adjust gene expression accordingly[1][3][7]. Because "blood cholesterol level regulation via bile acid binding/excretion" describes a pathway rather than a discrete molecule or receptor, it does not fit standard definitions for canonical molecular targets; instead it encompasses several key transporter proteins that are valid therapeutic targets individually. > “In hepatocytes, bile excretion occurs mainly at the canalicular membrane predominantly via ABC transporters... Cooperation among transporters is critical to maintaining bile homeostasis” [2]. > “Bile acids are amphipathic molecules synthesized from cholesterol in the liver... Recent studies suggest that agonists of peroxisome proliferator–activated receptors regulate lipoprotein metabolism... activation alters both synthesis and secretion pathways” [1]. Thus, *the entry "Blood cholesterol level regulation via bile acid binding/excretion"* should be mapped more specifically to individual *bile acid transporter* proteins or nuclear receptors involved in this pathway for structured data purposes.

Other names
Bile salt transportersABC transporters (specific members)Sodium/taurocholate cotransporting polypeptide (NTCP)Bile salt export pump (BSEP)Multidrug resistance-associated protein 2 (MRP2)ATP-binding cassette subfamily G member 5/8 (ABCG5/G8)
02

Mechanism of action

Inhibition or modulation of bile acid reabsorption/excretion to lower blood cholesterol by increasing conversion of cholesterol into bile acids and promoting their fecal elimination[1][3]

03

Biological functions

Cholesterol homeostasisBile acid excretion and reabsorptionLipid absorption facilitationRegulation of hepatic cholesterol catabolism
04

Disease associations

Cardiovascular diseaseMetabolic syndromeCholestasis and liver diseases
05

Safety considerations

Potential for fat-soluble vitamin deficiency due to impaired absorption when bile acid binding is excessiveGastrointestinal side effects from altered enterohepatic circulation
06

Interacting drugs

Bile acid sequestrants (e.g., cholestyramine, colesevelam; these bind bile acids in the gut to promote excretion)
07

Biomarkers

Serum cholesterol levelsSerum bile acid levels

Beyond the preview

Go deeper on Bile acid transporters.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bile acid transporters.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call